ATE283279T1 - Therapeutische inhaltsstoffe - Google Patents

Therapeutische inhaltsstoffe

Info

Publication number
ATE283279T1
ATE283279T1 AT94915474T AT94915474T ATE283279T1 AT E283279 T1 ATE283279 T1 AT E283279T1 AT 94915474 T AT94915474 T AT 94915474T AT 94915474 T AT94915474 T AT 94915474T AT E283279 T1 ATE283279 T1 AT E283279T1
Authority
AT
Austria
Prior art keywords
antagonists
biologically
peptides
therapeutic ingredients
pharmaceutical compositions
Prior art date
Application number
AT94915474T
Other languages
English (en)
Inventor
Ahmed Abdullah Azad
Cyril C Curtain
A Greenway
D A Mcphee
Ian Macreadie
Original Assignee
Macfarlane Burnet Ct For Medic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macfarlane Burnet Ct For Medic filed Critical Macfarlane Burnet Ct For Medic
Application granted granted Critical
Publication of ATE283279T1 publication Critical patent/ATE283279T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94915474T 1993-05-18 1994-05-18 Therapeutische inhaltsstoffe ATE283279T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL886193 1993-05-18
PCT/AU1994/000254 WO1994026776A1 (en) 1993-05-18 1994-05-18 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ATE283279T1 true ATE283279T1 (de) 2004-12-15

Family

ID=3776902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94915474T ATE283279T1 (de) 1993-05-18 1994-05-18 Therapeutische inhaltsstoffe

Country Status (7)

Country Link
US (2) US5962635A (de)
EP (1) EP0717752B1 (de)
JP (1) JP3699112B2 (de)
AT (1) ATE283279T1 (de)
CA (1) CA2163212C (de)
DE (1) DE69434151D1 (de)
WO (1) WO1994026776A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500281A (ja) * 1994-02-14 1998-01-13 ザ マクファーレーン バーネット センター フォー メディカル リサーチ リミテッド 非病原性ｈｉｖ−１種
WO1998013377A1 (en) * 1996-03-06 1998-04-02 Biomolecular Research Institute Ltd. Cytotoxic peptides
US20050033022A1 (en) * 1997-09-26 2005-02-10 Smithkline Beecham Biologicals Sa Fusion proteins comprising HIV-1 Tat and/or Nef proteins
DE02708018T1 (de) * 2001-03-09 2004-09-30 Gene Stream Pty. Ltd. Neue expressionsvektoren
GB0417494D0 (en) * 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine
CA2577183C (en) * 2004-08-17 2014-02-18 Institut Gustave Roussy Mutated hiv nef for modulating immunity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349354A1 (de) * 1988-04-01 1990-01-03 Institut Pasteur Peptide PF10 bis PF19 von einem Retrovirus HIV, Verfahren zur Synthese dieser Peptide und ihre Verwendung, insbesondere zur Diagnose
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
JPH08500481A (ja) * 1992-05-11 1996-01-23 リボザイム・ファーマシューティカルズ・インコーポレーテッド ウイルスの複製を阻害するための方法および薬剤
GB9311043D0 (en) * 1993-05-28 1993-07-14 Medical Res Council Inhibitors of nef-cd4 binding

Also Published As

Publication number Publication date
EP0717752A4 (de) 1997-08-20
CA2163212A1 (en) 1994-11-24
JPH09501143A (ja) 1997-02-04
DE69434151D1 (de) 2004-12-30
WO1994026776A1 (en) 1994-11-24
JP3699112B2 (ja) 2005-09-28
US5962635A (en) 1999-10-05
US6197583B1 (en) 2001-03-06
CA2163212C (en) 2004-07-13
EP0717752B1 (de) 2004-11-24
EP0717752A1 (de) 1996-06-26

Similar Documents

Publication Publication Date Title
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
ATE549028T1 (de) Stabile analoga von glp-1
NO952744D0 (no) Cytokinbegrensende midler
RU95115239A (ru) Аналог эритропоэтина
ATE165100T1 (de) Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
DZ2509A1 (fr) Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.
NL300830I1 (nl) Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten
PT848720E (pt) Antagonistas da actividade oncogenica da proteina mdm2 e sua utilizacao no tratamento de cancros
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
BG104266A (en) Aminoterminally incised mcp-2 as haemokin antagonists
DE602004028246D1 (de) Analoga von peptiden der relaxin-superfamilie
DK1079849T3 (da) Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
ATE199160T1 (de) Hochaktive vip - antagonisten
ATE10364T1 (de) Retro-inverso analoga von c-terminalen pentaund hexapeptiden der verbindung p.
BR0312889A (pt) Polipeptìdeo t20 peguilado
ATE69727T1 (de) Zusammensetzung zur behandlung von an haemophilia- a-inhibitor leidenden kranken.
ATE283279T1 (de) Therapeutische inhaltsstoffe
ATE177843T1 (de) Peptomere mit erhöhter immunogenizität
HUP0001458A2 (hu) Specifikus hasnyálmirigy lipáz inhibitor hatású peptidek, ezeket tartalmazó gyógyszerkészítmények és diagnosztikai reagensek, valamint ezek alkalmazása
CA2370098A1 (en) Human beta-trcp protein
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE390440T1 (de) Neuroaktive peptide
CA2057612A1 (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
ES2061908T3 (es) Antagonistas competitivos de gonadoliberina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties